Foxo technologies launches bioinformatics services to revolutionize epigenetic data analysis

Minneapolis--(business wire)--foxo technologies inc.™ (nyseam: foxo), a leader in the field of commercializing epigenetic biomarker technology, today announced the launch of its cutting-edge bioinformatics services to accelerate breakthroughs in biology, biotechnology, and healthcare, and redefine the growing field of epigenetic research. foxo's bioinformatics services offers a comprehensive platform of advanced data solutions tailored to meet the specific needs of clients in academia, healthca.
FOXO Ratings Summary
FOXO Quant Ranking